)
Cathay Biotech (688065) investor relations material
Cathay Biotech Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 revenue rose 7.26% YoY to RMB937.7m and attributable net income rose 8.60% to RMB154.2m; 9M revenue grew 11.51% and attributable net income 16.93%.
9M operating cash flow increased 125.79% to RMB616.6m, primarily as revenue growth lifted customer collections.
Financial highlights
9M total profit reached RMB604.7m, up 20.13% YoY; net income attributable to shareholders was RMB527.0m, up 16.93%.
9M adjusted net income was RMB476.3m, up 11.13%; Q3 adjusted net income was RMB147.6m, up 11.70%.
9M operating revenue was RMB2,837.9m versus RMB2,545.0m a year earlier; operating costs were RMB2,280.9m versus RMB1,946.6m.
Key financial ratios and metrics
Basic and diluted EPS were RMB0.21 for Q3, up 5.00%; 9M EPS was RMB0.73, up 8.96%.
Weighted average ROE was 0.86% for Q3, up 0.05 percentage points; 9M ROE was 2.95%, up 0.06 percentage points.
Q3 R&D spending rose 42.66% to RMB79.0m; 9M spending rose 15.17% to RMB205.7m.
R&D spending was 8.42% of Q3 revenue, up 2.09 percentage points; the 9M ratio was 7.25%, up 0.23 percentage points.
Total assets were RMB24.61bn at quarter-end, up 3.06% from year-end; parent shareholders’ equity was RMB17.92bn, up 1.25%.
- Revenue and net profit surged on business expansion and new product lines, with robust R&D investment.688065
Q2 2026 - Revenue and net profit rose strongly, but operating cash flow turned negative.688065
Q1 2026 - Revenue and net profit hit record highs, supported by strong core product sales and capital infusion.688065
H2 2025 - Q3 net profit jumped 45.30% year-over-year on robust sales and margin growth.688065
Q3 2025 - Net profit surged 24.74% year-over-year on robust bio-based materials sales and capital infusion.688065
H1 2025 - Q3 revenue jumped 44% and net profit rose 36% year-over-year, driven by strong sales and new products.688065
Q3 2024 - Revenue up 40% YoY, net profit up, capacity and R&D expansion ongoing.688065
H1 2024 - Net profit jumped 30% year-over-year on robust sales, despite lower operating cash flow.688065
Q1 2025
Next Cathay Biotech earnings date
Next Cathay Biotech earnings date
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)